168 related articles for article (PubMed ID: 1518025)
1. Investigation of a female manifesting Becker muscular dystrophy.
Glass IA; Nicholson LV; Watkiss E; Johnson MA; Roberts RG; Abbs S; Brittain-Jones S; Boddie HG
J Med Genet; 1992 Aug; 29(8):578-82. PubMed ID: 1518025
[TBL] [Abstract][Full Text] [Related]
2. Muscle X-inactivation patterns and dystrophin expression in Duchenne muscular dystrophy carriers.
Matthews PM; Benjamin D; Van Bakel I; Squier MV; Nicholson LV; Sewry C; Barnes PR; Hopkin J; Brown R; Hilton-Jones D
Neuromuscul Disord; 1995 May; 5(3):209-20. PubMed ID: 7633186
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy.
Nicholson LV; Johnson MA; Gardner-Medwin D; Bhattacharya S; Harris JB
Acta Neuropathol; 1990; 80(3):239-50. PubMed ID: 2205076
[TBL] [Abstract][Full Text] [Related]
4. Quadriceps myopathy: forme fruste of Becker muscular dystrophy.
Sunohara N; Arahata K; Hoffman EP; Yamada H; Nishimiya J; Arikawa E; Kaido M; Nonaka I; Sugita H
Ann Neurol; 1990 Nov; 28(5):634-9. PubMed ID: 2260849
[TBL] [Abstract][Full Text] [Related]
5. Manifesting carrier of Becker muscular dystrophy (BMD): clinical and recombinant DNA studies.
Ionasescu VV; Searby CC; Ionasescu R
Acta Neurol Scand; 1989 Jun; 79(6):500-3. PubMed ID: 2782030
[TBL] [Abstract][Full Text] [Related]
6. Prediction of dystrophin phenotype by DNA analysis in Duchenne/Becker muscular dystrophy.
Specht LA; Beggs AH; Korf B; Kunkel LM; Shapiro F
Pediatr Neurol; 1992; 8(6):432-6. PubMed ID: 1476571
[TBL] [Abstract][Full Text] [Related]
7. X inactivation and dystrophin studies in a t(X;12) female: evidence for biochemical normalization in Duchenne muscular dystrophy carriers.
Wenger SL; Steele MW; Hoffman EP; Barmada MA; Wessel HB
Am J Med Genet; 1992 Aug; 43(6):1012-5. PubMed ID: 1415326
[TBL] [Abstract][Full Text] [Related]
8. Skewed X inactivation in a female MZ twin results in Duchenne muscular dystrophy.
Richards CS; Watkins SC; Hoffman EP; Schneider NR; Milsark IW; Katz KS; Cook JD; Kunkel LM; Cortada JM
Am J Hum Genet; 1990 Apr; 46(4):672-81. PubMed ID: 2180286
[TBL] [Abstract][Full Text] [Related]
9. Becker muscular dystrophy: demonstration of the carrier status of a female by immunoblotting and immunostaining.
Chevron MP; Tuffery S; Echenne B; Demaille J; Claustres M
Neuromuscul Disord; 1992; 2(1):47-50. PubMed ID: 1525558
[TBL] [Abstract][Full Text] [Related]
10. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
Voit T; Stuettgen P; Cremer M; Goebel HH
Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822
[TBL] [Abstract][Full Text] [Related]
11. [Muscular dystrophies detected by immunophenotyping and genotype analysis (mRNA and DNA)].
Lukás Z; Vojtísková M; Fajkusová L; Bednarík J; Kadanka Z; Hájek J; Hermanová M; Vohánka S; Vytopil M
Cesk Patol; 2001 Nov; 37(4):137-45. PubMed ID: 11813630
[TBL] [Abstract][Full Text] [Related]
12. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin.
England SB; Nicholson LV; Johnson MA; Forrest SM; Love DR; Zubrzycka-Gaarn EE; Bulman DE; Harris JB; Davies KE
Nature; 1990 Jan; 343(6254):180-2. PubMed ID: 2404210
[TBL] [Abstract][Full Text] [Related]
13. A model to estimate the expression of the dystrophin gene in muscle from female Becker muscular dystrophy carriers.
Vainzof M; Passos-Bueno MR; Pavanello RC; Schreiber R; Zatz M
J Med Genet; 1992 Jul; 29(7):476-9. PubMed ID: 1640426
[TBL] [Abstract][Full Text] [Related]
14. Intrafamilial variability in dystrophin abundance correlated with difference in the severity of the phenotype.
Vainzof M; Passos-Bueno MR; Takata RI; Pavanello Rde C; Zatz M
J Neurol Sci; 1993 Oct; 119(1):38-42. PubMed ID: 8246009
[TBL] [Abstract][Full Text] [Related]
15. Dystrophin analysis using a panel of anti-dystrophin antibodies in Duchenne and Becker muscular dystrophy.
Muntoni F; Mateddu A; Cianchetti C; Marrosu MG; Clerk A; Cau M; Congiu R; Cao A; Melis MA
J Neurol Neurosurg Psychiatry; 1993 Jan; 56(1):26-31. PubMed ID: 8429320
[TBL] [Abstract][Full Text] [Related]
16. Becker muscular dystrophy: detection of unusual disease courses by combined approach to dystrophin analysis.
Gold R; Kress W; Meurers B; Meng G; Reichmann H; Müller CR
Muscle Nerve; 1992 Feb; 15(2):214-8. PubMed ID: 1549142
[TBL] [Abstract][Full Text] [Related]
17. Becker-like muscular dystrophy in sisters.
Diószeghy P; Molnár M; Mechler F
Eur Arch Psychiatry Clin Neurosci; 1995; 245(6):326-30. PubMed ID: 8527470
[TBL] [Abstract][Full Text] [Related]
18. Identification of a point mutation and germinal mosaicism in a Duchenne muscular dystrophy family.
Wilton SD; Chandler DC; Kakulas BA; Laing NG
Hum Mutat; 1994; 3(2):133-40. PubMed ID: 8199594
[TBL] [Abstract][Full Text] [Related]
19. Variability in clinical, genetic and protein abnormalities in manifesting carriers of Duchenne and Becker muscular dystrophy.
Bushby KM; Goodship JA; Nicholson LV; Johnson MA; Haggerty ID; Gardner-Medwin D
Neuromuscul Disord; 1993 Jan; 3(1):57-64. PubMed ID: 8329890
[TBL] [Abstract][Full Text] [Related]
20. Distinction of Becker from limb-girdle muscular dystrophy by means of dystrophin cDNA probes.
Norman A; Thomas N; Coakley J; Harper P
Lancet; 1989 Mar; 1(8636):466-8. PubMed ID: 2563842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
